Serum lipids in Brazilian children and adolescents: determining their reference intervals

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP SLHESSARENKO, Natasha
JACOB, Cristina M. A. FMUSP-HC
ANDRIOLO, Adagmar 2015
dc.identifier.citation BMC PUBLIC HEALTH, v.15, article ID 18, 8p, 2015
dc.identifier.issn 1471-2458
dc.description.abstract Background: Demographic, geographic, environmental and genetic factors influence lipids. In many countries, the normal lipid ranges for laboratory tests are based on references from American children and adolescents. In this work, we determined the reference intervals (RIs) for total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), non-high-density lipoprotein cholesterol (nHDL-c), low-density lipoprotein cholesterol (LDL-c) and triglycerides (TG) in Brazilian healthy children and adolescents. Methods: A cross-sectional study was conducted of 1,866 randomly sampled healthy children and adolescents from kindergartens and schools. Blood samples were collected after a variable period of fasting based on the age of the participant. The upper cut-off points were the 75th and 95th percentiles for TC, nHDL-c, LDL-c and TG. The 10th percentile (low) was used as the bottom level for HDL-c. Non-parametric tests were used for statistical analyses. Results: The following RI and 75th and 95th percentiles were observed for each age interval. The 95th percentile values obtained for TC were: 1 to 2 years, 189 mg/dL, 3 to 8 years, 199 mg/dL; 9 to 12 years, 205 mg/dL. For the nHDL c, the only age group 1 to 12 years, this percentile value was 150 mg/dL. For the LDL-cholesterol, the values corresponding to the percentiles above, aged 1 to 8 years and 9 to 12 years, were 132 mg/dL 139 mg/dL, respectively. For the triglycerides, the values corresponding to 95th percentile were: 1 year, 189 mg/dL; 2 to 5 years, 139 mg/dL; 6 to 12 years, 139 mg/dL. The 10th percentiles for HDL-c were 24 mg/dL, 28 mg/dL, 32 mg/dL and 36 mg/dL for children 1, 2, 3 and 4-12 years old, respectively. Conclusions: The lipid reference intervals defined in the studied Brazilian children and adolescents differ from those recommended by the international literature and should be used for clinical decisions contributing to improve the diagnosis in this particular group in our country.
dc.description.sponsorship · Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
· Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [-PQ2-308105/2012-5]
· Nucleo de Apoio a Pesquisa-USP (NAP-CriAd USP)
dc.language.iso eng
dc.relation.ispartof BMC Public Health
dc.rights openAccess
dc.subject Serum lipids; Reference intervals; Child; Adolescent
dc.subject.other pediatric reference intervals; childhood; schoolchildren; cholesterol; prevention; guidelines; profile
dc.title Serum lipids in Brazilian children and adolescents: determining their reference intervals
dc.type article
dc.rights.holder Copyright BIOMED CENTRAL LTD LIM/01 LIM/36
dc.identifier.doi 10.1186/s12889-015-1359-4
dc.identifier.pmid 25587248
dc.type.category original article
dc.type.version publishedVersion JACOB, Cristina M. A.:FM:MPE AZEVEDO, Raymundo S.:FM:MPT NOVAK, Glaucia V.:HC:ICR · SLHESSARENKO, Natasha:Univ Fed Mato Grosso, Julio Muller Sch Hosp, Cuiaba, MT, Brazil
· FONTES, Cor J. F.:Univ Fed Mato Grosso, Julio Muller Sch Hosp, Cuiaba, MT, Brazil
· ANDRIOLO, Adagmar:Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil 2-s2.0-84939185823 WOS:000349415300002 LONDON ENGLAND
hcfmusp.relation.reference · Adeli K, 2011, CLIN BIOCHEM, V44, P480, DOI 10.1016/j.clinbiochem.2011.02.017
· American Academy of Pediatrics, 1992, PEDIATRICS, V89, P525
· Klish WJ, 1998, PEDIATRICS, V101, P141
· Ceriotti F, 2012, CLIN CHEM, V58, P808, DOI 10.1373/clinchem.2012.183483
· Clinical and Laboratory Standards Institute (CLSI), 2008, C28A3 CLSI, V28, P30
· Colantonio DA, 2012, CLIN CHEM, V58, P1
· Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349
· Du JB, 2006, J APPL CLIN PEDIAT, V21, P801
· Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents National Heart Lung and Blood Institute, 2011, PEDIATRICS S5, V128, pS213, DOI 10.1542/PEDS.2009-2107C
· Ferreira CES, 2008, J BRAS PATOL MED LAB, V44, P1
· Friedberg RC, 2007, ARCH PATHOL LAB MED, V131, P348
· Giuliano Isabela de Carlos Back, 2005, Arq. Bras. Cardiol., V85, P85, DOI 10.1590/S0066-782X2005001500003
· Guiliano ICB, 2005, ARQ BRAS CARDIOL, V85, P85
· Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E
· KWITEROVICH PO, 1993, CORONARY ARTERY DIS, V4, P611, DOI 10.1097/00019501-199307000-00006
· Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270
· Liao Y, 2009, PEDIATR INT, V52, P472
· Moura EC, 2000, REV SAUDE PUBL, V34, P499, DOI 10.1590/S0034-89102000000500010
· National Cholesterol Education Program (NCEP), 1992, PEDIATRICS, V89, pS495
· National Heart Lung and Blood Institute (NHLBI), EXP PAN INT GUID CAR
· Pereira PB, 2010, ARQ BRAS CARDIOL, V95, P606, DOI 10.1590/S0066-782X2010005000136
· Ribas AS, 2009, ARQ BRAS CARDIOL, V92, P446
· Santos RD, 2012, ARQ BRAS CARDIOL, V99, P1
· Seki Mario, 2003, J. Bras. Patol. Med. Lab., V39, P309, DOI 10.1590/S1676-24442003000400008
· Seki Mario, 2003, J. Bras. Patol. Med. Lab., V39, P131, DOI 10.1590/S1676-24442003000200007
· Srinivasan SR, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e29
· Xavier H, 2013, ARQ BRAS CARDIOL S1, V101, P1, DOI 10.5935/ABC.2013S010
dc.description.index MEDLINE
hcfmusp.citation.scopus 2
hcfmusp.citation.wos 1 Brasil

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account